Coronado Research News

Coronado Research is a consultancy-led, professional services organisation, which provides support to pharmaceutical, biotechnology, and medical device companies. Our objective is to optimise the clinical development process by leveraging all the data available using AI, ML, and leading technologies.

Our practices cover Regulatory Strategy, Advanced Analytics, Market Access and Health Economics, and Technology. Our teams work with customers to “join-the-dots” between these disciplines to ensure treatments are developed with the end in mind and better match market needs.

PRESS RELEASE: Coronado Research Limited announce appointment of Alexander McCormick as Chief Commercial Officer …. read more

PRESS COVERAGE: Jennifer Visser-Rogers: Leading science transformation at Coronado Research ….. read more

PRESS COVERAGE: “Taking a Disruptive Approach” – interview published in ACRP Clinical Researcher” ….. read more

PRESS RELEASE: Coronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific Officer ….. read more

NEWS: Coronado Research Sponsor National Ice Hockey League 1 Team …. read more

OPINION PIECE: RBQM in Action: How Sponsors are Shaping the Future of Risk-Based Monitoring in Clinical Trials …. read more

PRESS RELEASE: Coronado Research announce engagement of Rob Nichols to support the growth of their Clinical Technology Practice …. read more

PRESS RELEASE: Coronado Research announce appointment of Gail Kniveton to Chief Talent Officer role …. read more

PRESS RELEASE: Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as Chair …. read more